Loading institutional data...
Loading institutional data...
Held by 211 of 5,944 reporting institutions (92th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $59.12 today, the market must believe free cash flow compounds 32.0%/yr for a decade (off $25M normalized FCF).
The market's 32.0% is more conservative than its 1-yr track record.
2-stage DCF · 0.05B shares · net debt -$106M
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Ranked against 1085 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCAX | $1.24T | — | — | — | — | — | — | -34.4% | -34.4% | — | 143 |
| LLY | $1.03T | 50.2× | — | 15.9× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $894.1B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $650.5B | 24.5× | — | 6.9× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $467.1B | 111.9× | 33.4× | 7.6× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| MRK | $368.2B | 20.2× | — | 5.7× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| UNH | $339.9B | 28.4× | 19.7× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| AZN | $257.7B | — | — | — | — | — | — | — | — | — | 1,248 |
| TMO | $248.2B | 37.1× | 31.9× | 5.6× | 3.9% | — | 15.0% | 12.6% | 7.0% | 4.9× | 2,481 |
| AMGN | $204.6B | 26.7× | 17.6× | 5.6× | 10.0% | 67.2% | 21.0% | 89.1% | 12.2% | 3.8× | 3,014 |
| GILD | $187.3B | 22.3× | 20.4× | 6.4× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| ABT | $178.0B | 27.5× | 19.2× | 4.0× | 5.7% | 56.4% | 14.7% | 12.5% | 10.0% | 1.4× | 2,964 |
| PFE | $157.1B | 20.3× | — | 2.5× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $150.2B | 42.1× | 31.0× | 6.1× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $136.2B | 48.7× | 37.5× | 13.5× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| VRTX | $131.1B | 33.7× | 28.8× | 10.9× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| BMY | $127.8B | 18.2× | — | 2.6× | -0.2% | 71.1% | 14.6% | 38.2% | 11.1% | — | 2,431 |
| MDT | $118.8B | 24.9× | 12.6× | 3.3× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| CVS | $114.7B | 64.9× | 11.5× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| SYK | $107.1B | 33.4× | 18.4× | 4.3× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| MCK | $102.5B | 22.9× | 16.2× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| HCA | $96.4B | 15.1× | — | 1.3× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $91.4B | 16.4× | 15.5× | 0.5× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| REGN | $82.6B | 19.0× | 19.8× | 5.8× | 1.0% | — | 31.4% | 14.4% | 13.6% | 0.5× | 1,336 |
| CI | $72.7B | 12.4× | 5.5× | 0.3× | 11.2% | 21.8% | 2.2% | 14.3% | 14.1% | 0.0× | 1,583 |
| ATRC | $2.9B | — | 1073.8× | 5.5× | 14.9% | 75.0% | -2.1% | -2.3% | -2.1% | 23.4× | 211 |
Peers = companies sharing ATRC's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on $48M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: -2%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $167M covers all $60M of scheduled principal — no refinancing pressure. Scheduled principal only (excludes interest & revolver draws). As of 2021-09-30 (10-Q).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~9.5% on $62M of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
Where each multiple sits in its own 14-yr range · 64th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 27.0 | 26.2 | 27.7 | 25.0 | 25.6 | 24.8 | 25.3 | 25.0 |
| Gross Profit | 73.0 | 73.8 | 72.3 | 75.0 | 74.4 | 75.2 | 74.7 | 75.0 |
| R&D | 17.2 | 17.9 | 20.9 | 17.7 | 17.4 | 18.5 | 20.7 | 18.6 |
| SG&A | 64.2 | 72.4 | 73.0 | 74.6 | 70.0 | 63.4 | 62.6 | 58.2 |
| Operating Income | -8.5 | -14.4 | -21.4 | 20.1 | -12.9 | -6.7 | -8.6 | -1.8 |
| Income Tax | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 |
| Net Income | -10.5 | -15.2 | -23.3 | 18.3 | -14.1 | -7.6 | -9.6 | -2.1 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on ATRC: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $534.5M 100.0% | $465.3M 100.0% | $399.2M 100.0% | $330.4M 100.0% | $274.3M 100.0% | $206.5M 100.0% | $230.8M 100.0% | $201.6M 100.0% | $174.7M 100.0% | $155.1M 100.0% |
| Cost of Revenue | $133.7M 25.0% | $117.8M 25.3% | $98.9M 24.8% | $84.4M 25.6% | $68.5M 25.0% | $57.2M 27.7% | $60.5M 26.2% | $54.5M 27.0% | $48.6M 27.8% | $44.0M 28.4% |
| Gross Profit | $400.8M 75.0% | $347.5M 74.7% | $300.4M 75.2% | $245.9M 74.4% | $205.9M 75.0% | $149.3M 72.3% | $170.3M 73.8% | $147.1M 73.0% | $126.2M 72.2% | $111.1M 71.6% |
| Research & Development | $99.2M 18.6% | $96.2M 20.7% | $73.9M 18.5% | $57.3M 17.4% | $48.5M 17.7% | $43.1M 20.9% | $41.2M 17.9% | $34.7M 17.2% | $34.1M 19.5% | $35.8M 23.1% |
| Selling, General & Admin | $311.0M 58.2% | $291.4M 62.6% | $253.1M 63.4% | $231.3M 70.0% | $204.6M 74.6% | $150.8M 73.0% | $167.1M 72.4% | $129.5M 64.2% | $117.0M 67.0% | $106.4M 68.6% |
| Total Operating Expenses | $410.2M 76.7% | $387.5M 83.3% | $327.1M 81.9% | $288.6M 87.4% | $150.7M 54.9% | $193.5M 93.7% | $203.5M 88.2% | $164.2M 81.5% | $151.1M 86.5% | $142.2M 91.7% |
| Operating Income | -$9.4M -1.8% | -$40.0M -8.6% | -$26.7M -6.7% | -$42.7M -12.9% | $55.2M 20.1% | -$44.2M -21.4% | -$33.1M -14.4% | -$17.1M -8.5% | -$25.0M -14.3% | -$31.1M -20.1% |
| Interest Expense | $5.9M 1.1% | $6.4M 1.4% | $6.9M 1.7% | $5.0M 1.5% | $4.9M 1.8% | $4.9M 2.4% | $4.1M 1.8% | $4.6M 2.3% | $2.3M 1.3% | $1.8M 1.2% |
| Interest & Investment Income | $4.5M 0.8% | $4.4M 1.0% | $3.8M 0.9% | $2.0M 0.6% | $466K 0.2% | $1.1M 0.5% | $2.4M 1.0% | $1.0M 0.5% | $227K 0.1% | $227K 0.1% |
| Other Income (Expense), net | $683K 0.1% | -$326K -0.1% | -$31K -0.0% | -$537K -0.2% | -$366K -0.1% | -$24K -0.0% | -$160K -0.1% | -$183K -0.1% | $138K 0.1% | -$586K -0.4% |
| Pretax Income | -$10.2M -1.9% | -$43.7M -9.4% | -$29.8M -7.5% | -$46.2M -14.0% | $50.4M 18.4% | -$48.0M -23.3% | -$35.0M -15.2% | -$20.9M -10.4% | -$26.9M -15.4% | -$33.3M -21.5% |
| Income Tax Expense | $1.3M 0.2% | $1.0M 0.2% | $591K 0.1% | $268K 0.1% | $188K 0.1% | $114K 0.1% | $199K 0.1% | $226K 0.1% | $14K 0.0% | $40K 0.0% |
| Net Income | -$11.4M -2.1% | -$44.7M -9.6% | -$30.4M -7.6% | -$46.5M -14.1% | $50.2M 18.3% | -$48.2M -23.3% | -$35.2M -15.2% | -$21.1M -10.5% | -$26.9M -15.4% | -$33.3M -21.5% |
| Per Share | ||||||||||
| EPS (Basic) | $-0.24 | $-0.95 | $-0.66 | $-1.02 | $1.11 | $-1.14 | $-0.94 | — | — | — |
| EPS (Diluted) | $-0.24 | $-0.95 | $-0.66 | $-1.02 | $1.09 | $-1.14 | $-0.94 | — | — | — |
| Weighted Avg Shares (Basic) | 47.8M | 47.0M | 46.3M | 45.7M | 45.1M | 42.1M | 37.6M | — | — | — |
| Weighted Avg Shares (Diluted) | 47.8M | 47.0M | 46.3M | 45.7M | 46.0M | 42.1M | 37.6M | — | — | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.